Chad M. Robins, CEO and Chairman at Adaptive Biotechnologies Corp (ADPT), sold 600,000 shares at $25.08 ($14.9M) on 2026-08-17, disclosed to the SEC on 2026-08-19.
Open-market sale of $14.9M ADPT by CEO and Chairman. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.08 | 318,799 | $8.0M | 53.7% |
| 2 | $25.57 | 2,525 | $65K | 0.4% |
| 3 | $24.48 | 278,472 | $6.8M | 45.8% |
| 4 | $25.14 | 204 | $5K | 0.0% |
| Total | $24.80 avg | 600,000 | $14.9M | 100% |
| Filing → |
| ADPT | SELL | 2026-03-03 | $8.3M | — | Filing → |
| ADPT | SELL | 2026-02-04 | $2.3M | — | Filing → |
| ADPT | SELL | 2026-01-07 | $1.9M | — | Filing → |